Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Neurology · Corticobasal Degeneration

Prognosis & Planning for the Future

At a Glance

For corticobasal degeneration, the course varies, but early planning can help families respond to swallowing and mobility changes, weigh feeding-tube benefits and burdens, involve palliative care, and document the person’s wishes for future treatment.

Thinking about the future with a progressive condition like Corticobasal Syndrome (CBS) or Corticobasal Degeneration (CBD) is deeply challenging. However, understanding the natural course of the disease is not about giving up; it is about empowerment. By discussing the road ahead early, you ensure that your loved one’s voice remains the guiding force in their care, even as the disease advances [1][2].

Understanding the Timeline

While every person’s experience with CBD is different, looking at the data can help with planning. For those with pathologically confirmed CBD, the median survival from first symptoms is typically between 6 and 7 years [3][4].

However, a median is not an individual forecast. Survival differs heavily based on the underlying pathology causing the CBS, and exact percentages from small cohorts may not predict your specific course. Some individuals live significantly longer, while others experience more rapid progression. These variations highlight why care must be personalized to the person in front of you, focusing on which current features—not a strict calendar—should guide planning.

Late-Stage Complications and Causes of Death

As CBD progresses, it increasingly affects the brain’s ability to control the “automatic” functions of the body.

  • Aspiration Pneumonia: This is the most common cause of death in people with CBS and CBD [5][6]. It occurs when the muscles used for swallowing become weakened or uncoordinated and food, liquid, or saliva enters the lungs, leading to infection [7].
  • Falls and Immobility: Falls and severe mobility challenges typically emerge as the disease progresses, with many patients eventually requiring significant assistance for transfers and daily care [4][5].
  • Dysphagia: Significant swallowing difficulties (dysphagia) are very common and often prompt major decisions regarding nutrition and safety [3][4].

The Feeding Tube Decision

One of the most complex decisions you may face is whether to place a gastrostomy tube (PEG tube or feeding tube) [8]. There is no “right” answer, only the answer that fits your loved one’s values.

  • Potential Benefits: A tube may help deliver nutrition, fluids, or medicines for some people. Some observational studies found an association where patients with atypical parkinsonism who received a feeding tube lived longer [3][8]. However, this is generally an observational association; it does not establish that the tube itself improves or prolongs survival in CBD.
  • The Limitations: Importantly, a feeding tube does not prevent aspiration pneumonia, because a person can still aspirate their own saliva or stomach reflux [8]. It also does not stop the underlying brain disease. It comes with burdens such as infection, reflux, tube complications, and occasionally the need for restraints if the patient pulls at the tube.
  • Quality of Life: For some, a tube provides relief. For others, the medical nature of the tube feels like an unacceptable burden [8]. A tube does not automatically end oral tastes; conversely, decisions should be based on a documented plan for comfort-focused hand feeding when appropriate.

The Role of Palliative Care

It is a common misconception that palliative care is only for the very end of life. Specialists recommend integrating palliative care as soon as possible after a diagnosis [9].

Palliative care focuses on “the whole person,” helping to manage difficult symptoms like pain or breathlessness while providing a space to talk through emotional weight [1][10]. It can run alongside disease-directed and rehabilitative care. It acts as a bridge, ensuring that the medical team and the family are all working toward the patient’s comfort and dignity [2]. (Hospice is a separate service for the end of life, and eligibility varies by jurisdiction.)

Advance Care Planning

Advance care planning is the process of documenting a “roadmap” for medical emergencies. Because CBS can eventually affect speech and cognition, these conversations should happen while your loved one can still easily participate [1]. Key items to address include:

  • Health Care Proxy: Naming the person who will make decisions if the patient cannot.
  • Ceilings of Care: Deciding in advance whether the patient would want a ventilator, CPR, or to be hospitalized for a lung infection. This is often documented in a POLST (Physician Orders for Life-Sustaining Treatment) or a local equivalent medical order [1].
  • Preferred Place of Care: Clarifying whether the patient wishes to remain at home as long as possible or would prefer a facility or hospice setting when needs become more intense [1].

By making these decisions now, you are not “giving up”; you are giving the gift of a care plan that honors their life and their wishes.

Common questions in this guide

What is the typical life expectancy with corticobasal degeneration?
In people with pathologically confirmed corticobasal degeneration, reported median survival from the first symptoms is about 6 to 7 years. This is a population statistic, not an individual prediction, and the course can differ substantially depending on the underlying disease and the person’s health.
What is the most common cause of death in corticobasal syndrome?
Aspiration pneumonia is a common cause of death in corticobasal syndrome and corticobasal degeneration. Swallowing problems can allow food, liquid, or saliva to enter the lungs, where it may cause infection.
Does a feeding tube prevent aspiration pneumonia in CBD?
No. A gastrostomy or PEG tube may provide nutrition, fluids, or medicines for some people, but it does not prevent aspiration of saliva or stomach reflux. Tube placement can also involve burdens such as infection, reflux, or other complications.
When should palliative care begin for someone with corticobasal degeneration?
Palliative care can be involved soon after diagnosis rather than waiting until the final stage of illness. It can work alongside disease-directed and rehabilitative care to manage symptoms, support caregivers, and help the family make decisions that fit the person's goals. Hospice is a separate service focused on end-of-life care.
What should advance care planning include for a person with CBS?
Advance care planning can identify a health-care proxy and record preferences about CPR, ventilators, hospitalization, and the preferred place of care. These decisions may be documented in an advance directive, POLST, or a comparable local medical order while the person can still communicate clearly.
What are the options if we decide against a feeding tube?
The care plan can focus on comfort, including careful hand feeding and oral tastes when appropriate, while addressing thirst, hunger, swallowing safety, and other symptoms. The treating team can help the family create a plan that respects the person's wishes and balances comfort with possible risks.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on corticobasal degeneration disorder.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the current 'ceiling of care' that best aligns with my loved one's values—are we focusing on maximizing time or maximizing comfort?
  2. 2.Based on the current degree of swallowing difficulty, how likely is it that a feeding tube would improve quality of life versus increasing the risk of discomfort?
  3. 3.If we choose not to pursue a feeding tube, what does 'comfort-focused' feeding look like, and how will we manage thirst and hunger?
  4. 4.What specific criteria would indicate that it is time to transition from palliative care to hospice services?
  5. 5.Can you help us document an advance directive or POLST that reflects our decisions about hospitalization and CPR?
  6. 6.How can we manage breathlessness or 'air hunger' if it becomes an issue in the later stages?

References

References (10)
  1. 1

    Palliative care in Parkinson disease and related disorders.

    Corcoran J, Huang AH, Miyasaki JM, Tarolli CG

    Handbook of clinical neurology 2023; (191()):107-128 doi:10.1016/B978-0-12-824535-4.00017-3.

    PMID: 36599503
  2. 2

    Progressive Supranuclear Palsy and Corticobasal Syndrome.

    McFarland NR

    Continuum (Minneapolis, Minn.) 2025; (31(4)):1023-1049 doi:10.1212/cont.0000000000001607.

    PMID: 40748119
  3. 3

    Clinical characteristics of Japanese patients with corticobasal degeneration.

    Tahara D, Tahara N, Akagi A, et al.

    Journal of the neurological sciences 2024; (466()):123212 doi:10.1016/j.jns.2024.123212.

    PMID: 39243604
  4. 4

    Clinical course of pathologically confirmed corticobasal degeneration and corticobasal syndrome.

    Aiba I, Hayashi Y, Shimohata T, et al.

    Brain communications 2023; (5(6)):fcad296 doi:10.1093/braincomms/fcad296.

    PMID: 38090279
  5. 5

    Prognostic factors of survival in corticobasal syndrome and corticobasal degeneration: A scoping review.

    Saim MS, Al-Kazzaz H, Ahmad H

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2026; (47(8)).

    PMID: 42527685
  6. 6

    Corticobasal degeneration preceded by cognitive impairment and apathy: An autopsy case report.

    Hirose S, Kobayashi R, Hatakeyama S, et al.

    PCN reports : psychiatry and clinical neurosciences 2025; (4(3)):e70174 doi:10.1002/pcn5.70174.

    PMID: 40756022
  7. 7

    Frequency and outcomes of gastrostomy insertion in a longitudinal cohort study of atypical parkinsonism.

    Kobylecki C, Chelban V, Goh YY, et al.

    European journal of neurology 2024; (31(6)):e16258 doi:10.1111/ene.16258.

    PMID: 38407533
  8. 8

    Percutaneous endoscopic gastrostomy in atypical parkinsonian syndromes: survival and aspiration outcomes from a retrospective international cohort.

    Ruttle T, Jones E, Towns C

    The New Zealand medical journal 2026; (139(1628)):40-49 doi:10.26635/6965.7117.

    PMID: 41610292
  9. 9

    Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment Options.

    Lamb R, Rohrer JD, Lees AJ, Morris HR

    Current treatment options in neurology 2016; (18(9)):42 doi:10.1007/s11940-016-0422-5.

    PMID: 27526039
  10. 10

    Corticobasal degeneration: clinical characteristics and multidisciplinary therapeutic approach in 26 patients.

    Shehata HS, Shalaby NM, Esmail EH, Fahmy E

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2015; (36(9)):1651-7 doi:10.1007/s10072-015-2226-x.

    PMID: 25917399

This page is for informational purposes only and does not constitute medical advice. Discuss feeding, palliative care, and advance-care decisions for corticobasal degeneration with the treating team.